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Introduction. Oxidative stress has a well-known role in diabetic 
nephropathy, and mitochondria are the major source of reactive 
oxygen species production. This study aimed to assess the effect of 
tempol, a superoxide dismutase mimetic agent, on mitochondrial 
antioxidant enzymes and cell viability in diabetic nephropathy.
Materials and Methods. Adult male Wistar rats were divided into 
4 groups of 7 animals. Diabetes mellitus was induced by injection 
of streptozotocin in 2 groups, the rat in one of which were also 
treated with tempol for 4 weeks. Another group without diabetes 
mellitus received tempol, and the last group was the control. At 
the end of the treatment period, the kidney mitochondria were 
isolated and their antioxidant enzymes, including superoxide 
dismutase, glutathione peroxidase, and catalase were assessed. 
Malondialdehyde, total antioxidant capacity, and kidney cells 
viability were studied, as well.
Results. The diabetic group was significantly different compared 
with the control group in malondialdehyde, catalase, and glutathione 
peroxidase activities. Superoxide dismutase and total antioxidative 
capacity did not show any significant differences among the four 
groups. Moreover, the diabetic group treated with tempol had 
significantly different glutathione peroxidase level and kidney 
cells viability, compared to the other diabetic group (P < .05)
Conclusions. Diabetic nephropathy induces changes in mitochondrial 
antioxidative biomarkers and cells viability, some of which can be 
modified by tempol administration in rats.
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INTRODUCTION
Oxidative stress is a well-known phenomenon in 
the pathogenesis of diabetic vascular complications, 
as well as nephropathy.1 On the other hand, 
mitochondria are known as the main sources 
of reactive oxygen species (ROS) creation in 
diabetes mellitus,2 and they are injured by the 
ROS as well. Mitochondrion is the main energy-
producing organelle in cells. It is a membrane-
enclosed structure found in most eukaryotic cells. 
Mitochondrial dysfunction plays an important 
role in diabetic nephropathy (DN).3 Mitochondria 
produce oxygen radicals while substrates are 
metabolized.4 This leads to oxidative injury, 
appearing in ways such as protein alteration,5 lipid 
membranes peroxidation,6 and mitochondrial DNA 
break.7 A couple of enzymes may protect against 
ROS in mitochondria. These include manganese 
superoxide dismutase (SOD), catalase, glutathione 
peroxidase (GP), etc.8
Conversely, nitroxide 4-hydroxy-2,2’,6,6’-
tetramethylpiperidine 1-oxyl, also known as tempol, 
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is a well-known SOD mimetic antioxidative agent. 
Tempol reduces severity of DN in SOD-knockout 
mice during streptozotocin-induced diabetes 
mellitus.9 Furthermore, tempol administration to 
obese hypertensive Zucker rats improved insulin 
sensitivity and reduced renal inflammation and 
fibrosis.10 Tempol also reduced renal mesangial 
expansion and decreased transforming growth 
factor-β in diabetic rats.11
In this study, we assessed kidney mitochondrial 
catalase, SOD, GP, total antioxidative capacity, 
lipid peroxidation (LP), and kidney cells viability, 
and moreover, tempol effect on these in different 
groups of rats including diabetic ones.
MATERIALS AND METHODS
Reagents and Chemicals
Chemicals used in the study were tetraethoxy 
propane (malondialdehyde), 2-thiobarbituric 
acid, trichloroacetic acid, n-butanol, sucrose, 
ethylenediaminetetraacetic acid, comassie blue, 
bovine serum albumin, 4,5(dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide, GP, and SOD 
(Ransel kit, Randox Laboratories Ltd, Crumlin, 
UK). All other chemicals were obtained from the 
Sigma.
Animals and Interventions
The study animals were adult male Wistar 
rats weighing 180 g to 250 g maintained on a 
12-hour light-dark cycle with free access to tap 
water and standard laboratory chow. The animals 
were randomly divided into 4 groups of 7 rats, 
as follows: control group, diabetic group, tempol 
group (tempol, 100 mg/kg/d, for 4 week), and 
diabetic tempol group (tempol, 100 mg/kg/d, 
for 4 week). Diabetes mellitus was induced using 
a streptozotocin injection (prepared by citrate 
buffer, pH 4.5; 1 dose, 60 mg/kg body weight; 
intraperitoneal), as validated in previous studies.12 
The fasting blood glucose levels were determined 
3 days after streptozotocin injection using a 
strip-operated blood glucose sensor. The animals 
were considered diabetic if plasma glucose levels 
exceeded 250 mg/dL. At the end of the treatment, 
24 hours postintervention, the animals were killed, 
the kidney tissue was separated and stored in liquid 
nitrogen, and then their mitochondria were isolated 
quickly and kept frozen at -80°C. All procedures 
for the treatment of the animals were approved 
by the research ethics committee of Hamadan 
University of Medical Sciences.
Kidney Parameters
Blood urea nitrogen, serum creatinine, urine 
albumin, and urine creatinine levels were estimated 
using an automated biochemistry machine, 
 according to the standard procedure of kits.
Preparation of Kidney Mitochondria
The kidney tissues were removed and minced 
with small scissors in a cold manitol solution 
containing 0.225 M of D-manitol, 75 mM of sucrose, 
and 0.2 mM of ethylenediaminetetraacetic acid. The 
minced kidney (30 g) was gently homogenized in 
a glass homogenizer with a Teflon pestle and then 
centrifuged at 700 g for 10 minutes at 4°C to remove 
nuclei, unbroken cells, and other nonsubcellular 
tissue. The supernatants were centrifuged at 7000 
g for 20 minutes. These second supernatants were 
pooled as the crude microsomal fraction and the 
pale loose upper layer of sediments, which was 
rich in swollen or broken mitochondria, lysosomes, 
and some microsomes, was washed away.
The dark packed lower layer (heavy mitochondrial 
fraction) was resuspended in the manitol solution 
and recentrifuged twice at 7000 g for 20 minutes. 
The  heavy mitochondria l  sediments  were 
suspended in Tris solution containing 0.05 M 
of Tris-hydrochloride buffer (pH 7.4), 0.25 M of 
sucrose, 20 mM of potassium chloride, 2.0 mM 
of magnesium chloride, and 1.0 mM of disodium 
phosphate at 4°C before assay.13
Assay of Superoxide Dismutase Activity
The activity of SOD was measured using a 
commercial kit (Ransod kit, Randox Laboratories 
Ltd, Crumlin, UK). Measurement of the enzyme 
was based on the generation of superoxide radicals 
produced by xanthine and xanthine oxidase and 
reacted with 2-(4-iodophenyl)-3-(4-nitrofenol) 
5-phenyltetrazolium chloride to form a red formazan 
dye. The formazan was read at 505 nm. One unit of 
SOD was defined as the amount of enzyme necessary 
to produce 50% inhibition in the 2-(4-iodophenyl)-
3-(4-nitrofenol) 5-phenyltetrazolium chloride 
reduction rate.
Assay of Glutathione Peroxidase Activity
The amount of GP was determined using a 
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commercially available kit (Ransel kit, Randox 
Laboratories Ltd, Crumlin, UK) by measuring 
the rate of oxidation of nicotinamide adenine 
dinucleotide phosphate at 340 nm. A unit of 
enzyme was expressed as the amount of enzyme 
needed to oxidize 1 nmol of nicotinamide adenine 
dinucleotide phosphate oxidase/minute.
Assay of Lipid Peroxidation
The LP product in tissues was determined by 
2-thiobarbituric acid reagent, expressed as the 
extent of malondialdehyde production during an 
acid heating reaction. Brieﬂy, the samples were 
diluted by 1.5 mL of trichloroacetic acid (20% w/v), 
added to 250 μL of this samples, and centrifuged 
in 3000 g for 10 minutes. Then, the precipitation 
was dissolved in sulfuric acid, and 1.5 mL of the 
mixture was added to 1.5 mL of 2-thiobarbituric 
acid (0.2% w/v). The mixture was then incubated 
for 1 hour in a boiling water bath. Following 
incubation, 2 mL of n-butanol was added, the 
solution centrifuged, cooled, and the absorption 
of the supernatant was recorded in 532 nm. The 
calibration curve of tetraethoxypropane standard 
solutions was used to determine the concentrations 
of 2-thiobarbituric acid plus malondialdehyde 
adducts in samples.14
Assay of Catalase Activity
Catalase activity was assayed in the samples by 
measuring the absorbance decrease at 240 nm in 
a reaction medium containing hyrogen peroxide 
(10 mM), sodium phosphate buffer (50 mM, pH 
7.0). One unit of the enzyme was defined as 1 mol 
of hydrogen peroxide as substrate consumed per 
minute, and the specific activity was reported as 
units per milligram of protein.15
Assay of Total Antioxidant Capacity
The total antioxidant capacity was measured 
by ferric-reducing ability of plasma method. 
This method is based on the ability of plasma 
in reducing ferric to ferrous in the presence of 
2,4,6-tripyridyl-S-triazine. The reaction of ferrous 
and 2,4,6-tripyridyl-S-triazine gives a complex 
with a blue color and maximum absorbance in 
593 nm.16
Total Protein
The protein content was quantiﬁed by the method 
of Bradford. Concentrated Coomassie blue was 
diluted in 250 μL of distilled water, and then 750 μL 
of this diluted dye was added to 50 μL of the sample. 
The mixture was incubated at room temperature 
for 10 minutes and an absorbance measurement 
was taken at 595 nm by a spectrophotometer. A 
standard curve was constructed by using bovine 
serum albumin ranging between 0.25 mg/mL and 
1 mg/mL.17
Assay of Cell Viability
The cell  viabil i ty assay is  a quantitative 
colorimetric method to determine cell viability. 
It utilizes the yellow tetrazolium salt, which is 
metabolized by mitochondrial dehydrogenase 
enzyme from viable cells to yield a purple 
formazan reaction product that was determined 
spectrophotometrically at wavelength of 570 nm. 
The percentage of cell viability of each test sample 
was calculated.18
Statistical Analysis
The mean and standard error values were 
determined for all the parameters and the results 
were expressed as mean ± standard deviation. Data 
normality was accessed using the Kolmogrov-
Smirnov test and the 1-way analysis of variance 
was used to determine if there was any differences 
between the four groups. Differences were 
considered significant when the P value was less 
than .05. The SPSS software (Statistical Package 
for the Social Sciences, version 18.0, SPSS Inc, 
Chicago, IL, USA).
RESULTS
Diabetes Induction
After 3 days of follow-up, diabetes mellitus 
( fas t ing  b lood g lucose  >  250  mg/dL)  was 
induced in the rats which received streptozotocin 
intraperitoneally. Diabetic nephropathy was 
confirmed by significant rising of albumin-creatinine 
ratio after 4 weeks (258 ± 28 in the control group 
versus 2000 ± 26 in the diabetic groups). Blood urea 
nitrogen also increased (44 ± 3.39 mg/dL versus 
60.4 ± 2.8 mg/dL, respectively), but not serum 
creatinine (0.61 ± 0.06 mg/dL versus 0.66 ± 0.04 
mg/dL, respectively).
Superoxide Dismutase Activity
One unit of SOD was defined as the amount 
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of enzyme necessary to produce 50% inhibition 
i n  t h e  2 - ( 4 - i o d o p h e n y l ) - 3 - ( 4 - n i t r o f e n o l ) 
5-phenyltetrazolium chloride reduction rate. It 
increased in the diabetic group, compared with 
the control group and decreased by tempol 
administration in the diabetic tempol group. 
However, there was no significant difference 
among the four groups.
Catalase Activity
One unit of the enzyme was defined as 1 mol 
of hydrogen peroxide as substrate consumed per 
minutes. It was significantly higher in the diabetic 
group, compared with the control group. Tempol 
administration, however, decreased catalase activity 
in the diabetic rats insignificantly (Figure 1).
Glutathione Peroxidase Activity
One unit of enzyme was expressed as the 
amount of enzyme needed to oxidize 1 nmol of 
nicotinamide adenine dinucleotide phosphate 
oxidase per minute. Unlike the other enzymes, 
GP was lower in the diabetic versus control rats 
(P < .05) and raised in the diabetic tempol group 
significantly (Figure 1).
Lipid Peroxidation Activity
Lipid peroxidation production was determined 
by the extent of malondialdehyde creation during 
an acid heating reaction. Compare to control 
group, malondialdehyde increased in the diabetic 
group notably, but was not affected by tempol 
administration (Figure 1).
Total Antioxidative Capacity
The total  antioxidative capacity was not 
significantly different between the four animal 
groups.
Kidney Cells Viability
Diabetes mellitus induction decreased viability of 
cells in comparison to the controls, and on the other 
hand, tempol administration significantly increased 
it (P  < .05; Figure 1). Moreover, correlations 
between kidney cells viability and superoxide 
dismutase, catalase, and malondialdehyde activities 
were moderate, indirect, and significant (P < .05; 
Figure 2), while the correlation with glutathione 
peroxidase was weak (r = 0.33) and nonsignificant 
(P > .05).
DISCUSSION
Manganese  SOD,  which is  an important 
antioxidative enzyme, mainly regulates ROS 
Figure 1. Changes of kidney mitochondrial antioxidative 
enzymes and kidney cells viability in diabetic and nondiabetic 
rats and the impact of tempol.
*P < .05 compared with the control group
†P < .05 compared with the diabetic group
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metabolism in the mitochondria. Consequently, its 
activity might be reduced with ROS exposure.19 
Circumstances that direct to manganese SOD 
dysfunction lead to tissue damage coupled with 
DN. On the other hand, resveratrol, a well-known 
antioxidant agent, improved kidney injury and 
mitochondrial biogenesis in the kidney of db/
db mice, via normalization of manganese SOD 
function.20 Conversely, Munusamy and MacMillan-
Crow showed that manganese SOD activity was not 
altered in hyperglycemic milieu in the early stages 
of diabetes mellitus.21 Our study showed similar 
results with tempol administration. Conversely, 
kidney cells viability diminishes in hyperglycemic 
milieu, as we showed and the relationship between 
SOD and kidney cells viability was indirect and 
significant. Therefore, it seems manganese SOD 
compensates by rising its activity per remaining 
cells.
Catalase has classically been considered a 
cytoplasmic enzyme. However, recent studies have 
documented its activity in heart mitochondria.22 
Furthermore, catalase was significantly upregulated 
in heart mitochondria of diabetic rats.23 We showed 
the same modification in kidney mitochondria. 
Again, augmentation per cells, presumably, pays 
off diminishing viable cells. Nevertheless, it 
did not changed significantly following tempol 
administration.
In contrast to Moreira and colleagues,24 we 
showed downregulation of glutathione peroxidase 
in kidney mitochondria of the diabetic rats, which 
improved significantly by tempol administration. It 
may be explained by different periods of diabetes 
mellitus induction of rats (4 weeks versus 12 weeks).
Malondialdehyde is one of the well-known 
end products of lipid peroxidation and is an 
indicator of oxidative stress injury.25 Mitochodrial 
malondialdehyde was increased significantly in 
the DN groups. Moreover, we showed that kidney 
cells viability decreased significantly in DN, which 
could be improved by tempol administration. Yu 
and colleagues26 showed that viability of glomerular 
mesangial cell and SOD were decreased in high 
glucose milieu. Conversely, malondialdehyde was 
increased, which could be modified by a different 
dosage of a kind of ginseng sapogenin (PPD). Our 
study showed a significant correlation between 
kidney cells viability and malondialdehyde.
All mitochondrial antioxidative enzymes, with the 
exception of GP, had moderate, significant, and of 
course indirect correlation with kidney cells viability. 
It indicates that in oxidative stress circumstance, 
these enzymes activity increases to compensate 
reduced cell viability. However, this is not the case 
about GP. It gives the impression that this enzyme 
activity remains invariable per cell, still in diabetic 
oxidative stress. It is well known that GP activity 
depends on glucose-6- phosphate dehydrogenase 
action, which already lessens in diabetic milieu, 
and it perhaps explains why GP is an exception. 
The mechanisms responsible for the decrease of 
glucose-6- phosphate dehydrogenase activity are 
not fully known. Xu and coworkers27 proposed 
that decreased expression and posttranslational 
Figure 2. Correlation between kidney cells viability and 
mitochondrial antioxidative enzymes.
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modification played a role equally. Hence, this 
study give us an idea about different mechanism 
of regulating antioxidant enzymes, which should 
be evaluated deliberately by further studies. To 
the best of our knowledge, this is the first report 
describing correlation of kidney cells viability 
with mitochondrial antioxidative enzymes in DN.
CONCLUSIONS
O x i d a t i v e  s t r e s s  s e v e r e l y  i m p a c t s  D N . 
Mitochondria on the other hand, have major role 
in generating and also are injured by ROS. We 
studied changes of a couple kidney mitochondrial 
enzymes and tempol effects on them for the first 
time. Moreover, we showed that kidney cells 
viability was altered by tempol in DN.
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